¿Qué es la rectitis sifilítica?

Respuesta generada por Itaca · 49 fuentes · 12 de noviembre de 2025

Pregunta original

Rectitis sifilitica

Syphilitic Proctitis: A Comprehensive Clinical Review for Healthcare Professionals

Executive Summary: Syphilitic proctitis, also known as rectitis sifilitica or rectal syphilis, is a rare but increasingly recognized manifestation of Treponema pallidum infection that presents a significant diagnostic challenge due to its capacity to mimic rectal malignancy, inflammatory bowel disease, and other infectious etiologies. This condition occurs predominantly in men who have sex with men (MSM) and patients with HIV coinfection, representing both primary chancres during early infection and secondary manifestations during disseminated disease. The clinical presentation is nonspecific and lacks pathognomonic features, frequently resulting in delayed diagnosis and inappropriate treatment including unnecessary surgical interventions. Serologic testing combined with detailed sexual history and compatible endoscopic findings remains essential for diagnosis, while benzathine penicillin G remains the cornerstone of therapy. Early recognition and appropriate antibiotic treatment offer excellent prognosis and prevent serious complications including neurosyphilis, cardiovascular involvement, and permanent organ dysfunction.

Epidemiology and Disease Prevalence

Syphilitic proctitis represents a rare but increasingly significant manifestation of sexually transmitted syphilis, particularly among high-risk populations. The epidemiological landscape of this condition reflects broader trends in syphilis transmission and the disproportionate burden of infection among specific demographic groups. According to global surveillance data, syphilis remains a significant public health concern, with approximately 5 million new cases diagnosed annually worldwide.[1][2] Among these cases, men who have sex with men account for a substantial majority, with estimates suggesting that approximately 75 percent of syphilis cases involve unprotected anal intercourse.[1][2] This transmission route has direct implications for the prevalence of anorectal manifestations including syphilitic proctitis.

Within the broader context of syphilis epidemiology, rectal involvement represents only a small percentage of total cases. Among patients with isolated infectious proctitis caused by sexually transmitted pathogens, syphilis accounts for approximately 2 percent of cases, with Neisseria gonorrhoeae and Chlamydia trachomatis remaining more prevalent at 30 percent and 19 percent respectively.[3] However, the actual frequency of syphilitic proctitis may be underestimated due to diagnostic challenges and the tendency for clinicians to overlook this possibility in differential diagnosis. In recent decades, there has been a notable reemergence of syphilis across multiple developed nations, paralleling changes in sexual behavior and prevention practices. Between 2005 and 2013, the Centers for Disease Control and Prevention documented that the number of primary and secondary syphilis cases reported nearly doubled from 8,724 to 16,663, with the majority of these cases occurring among MSM.[4][5]

The prevalence of syphilis and HIV coinfection represents a particularly important epidemiologic feature, as this combination frequently occurs in affected populations. Syphilis and HIV coinfection rates vary considerably by geographic region and population, with estimates ranging from 45 to 79 percent among specific high-risk groups.[1][2] In a Colombian study examining HIV-positive MSM, the overall prevalence of syphilis was 0.7 percent, with coinfection prevalence at 0.6 percent; however, among MSM without health insurance affiliation who had sexual partners with HIV, the T. pallidum prevalence reached 12.1 percent, emphasizing the role of social determinants and risk networks in disease transmission.[6] These epidemiologic patterns underscore that syphilitic proctitis should be considered within the context of intersecting risks for sexually transmitted infections and the documented association between receptive anal intercourse and anorectal disease acquisition.

Geographic variation in syphilis prevalence also influences the likelihood of encountering syphilitic proctitis in clinical practice. Areas with higher overall syphilis burden demonstrate correspondingly higher rates of anorectal involvement. Furthermore, behavioral factors including frequency of receptive anal intercourse, number of sexual partners, and patterns of condom use significantly influence individual and population-level risk. The World Health Organization has defined endemic syphilis prevalence as occurring when rates exceed 5 percent in specific populations, and these regions experience higher rates of all syphilis manifestations including rectal disease. Understanding these epidemiologic patterns is essential for clinicians practicing in settings with significant MSM populations or serving patients with documented HIV infection.

Pathophysiology and Disease Mechanisms

Syphilitic proctitis results from direct inoculation of the spirochete Treponema pallidum into the rectal mucosa, typically through receptive anal intercourse with an infected partner who has mucocutaneous lesions containing viable organisms. The pathogenic process begins when T. pallidum gains entry through microabrasions in the rectal epithelium, a process facilitated by the thin, delicate mucosa of the rectum and the mechanical trauma associated with anal intercourse. Once the organism enters the tissue, it begins a complex interaction with host immune mechanisms that characterizes the diverse clinical manifestations of syphilis.

The spirochete, with its characteristic thin, helical morphology measuring 6 to 15 microns in length, possesses specialized mechanisms for tissue invasion and survival within the host. T. pallidum utilizes its spiral shape to facilitate penetration through tissue planes and employs mucopolysaccharidase enzymes to enhance attachment to host cells.[7] The organism preferentially survives in an oxygen-poor environment and resists phagocytosis through mechanisms related to its sparse cell wall and absence of lipopolysaccharides. Following initial invasion, T. pallidum disseminates rapidly throughout the body, including early invasion of the central nervous system that may occur within hours of initial infection, though clinical manifestations of neurosyphilis develop only in a minority of untreated patients.[8]

The histopathological response to T. pallidum infection in the rectum is characterized by a distinctive inflammatory infiltrate composed primarily of lymphocytes, plasma cells, and histiocytes.[9][4] This infiltrate typically demonstrates a delayed hypersensitivity reaction pattern, reflecting T-cell mediated immunity to the organism. In biopsies from syphilitic proctitis cases, histologists observe extensive chronic inflammatory cell infiltration with variable degrees of acute inflammation, lymphoid follicle formation, and ulceration.[9] The abundant plasma cell infiltrate is particularly characteristic of syphilitic inflammation and reflects vigorous antibody production against T. pallidum antigens. Some cases demonstrate non-caseating granulomas with multinucleated giant cells, though these represent a minority of presentations and are not specific to syphilis.

The endothelial involvement observed in syphilitic lesions contributes significantly to the tissue damage and clinical manifestations. T. pallidum infection causes obliterative endarteritis, characterized by proliferation and swelling of vascular endothelium that can progress to complete arterial occlusion.[7] This vascular inflammation explains the tissue necrosis, ulceration, and mass-like lesions characteristic of secondary syphilis and advanced primary chancres. The inflammatory exudate and tissue destruction create the appearance of infiltrating lesions that readily mimic malignancy on radiologic and endoscopic examination.

Primary syphilitic chancres represent the initial local response to infection, characterized by induration, well-demarcated margins, and a clean, nonexudative base.[10] These lesions typically appear at the site of bacterial inoculation within 10 to 90 days (median 21 to 25 days) and are characteristically painless unless located in areas of mechanical trauma such as between the anal verge and dentate line.[11][12] The chancre in rectal locations can cause significant pain due to the continuous movement and pressure in this anatomic region, distinguishing rectal presentation from genital chancres which are typically described as entirely painless.

Secondary syphilis develops as disseminated infection, typically occurring 6 to 8 weeks after the primary chancre appears (though the incubation period may extend to 6 months), and represents hematogenous spread of the organism.[3][13] During secondary syphilis, T. pallidum multiplies and disseminates rapidly, triggering systemic immune responses. Rectal manifestations during secondary syphilis may include proctitis with ulceration, mass-like lesions, or mucosal inflammation mimicking primary chancres. The distinction between primary chancres that happen to be located rectally and secondary manifestations of syphilis presenting with rectal ulceration can be difficult clinically and histopathologically, and indeed both may coexist or overlap in their temporal presentation.

Clinical Manifestations and Presentations

The clinical presentation of syphilitic proctitis varies considerably, reflecting both the stage of syphilis (primary versus secondary) and individual factors including HIV status and degree of immunosuppression. This variability in presentation contributes substantially to diagnostic delays and misdiagnosis. Patients with syphilitic proctitis typically present with nonspecific anorectal symptoms that could be attributed to numerous other conditions. Common presenting symptoms include lower abdominal pain, tenesmus (persistent feeling of needing to defecate), rectal bleeding or hematochezia, mucous discharge, changes in bowel habits, and rectal pain or proctalgia.[14][3][13][15] Weight loss has been documented in some cases, particularly those with chronic symptoms.[4][5]

In some instances, syphilitic proctitis may present asymptomatically, with diagnosis made incidentally on endoscopic examination performed for other indications or through screening in high-risk populations.[14][13] However, when symptoms are present, they typically reflect local inflammation and mucosal ulceration. The duration of symptoms varies widely, from acute presentations lasting weeks to chronic symptoms persisting for months before diagnosis. One documented case involved a patient with an 11-month history of symptoms including rectal bleeding, tenesmus, weight loss, and mucoid rectal discharge before correct diagnosis was established.[4][5] The chronicity of untreated symptoms underscores the variable rate of disease progression and the importance of clinical vigilance even in patients with chronic anorectal complaints.

Physical examination findings vary depending on the stage and severity of infection. Digital rectal examination may reveal an indurated mass, anal fissures, nodularity, or ulceration depending on the specific presentation.[4][5][11] Some patients have been documented with tender fungating masses protruding from the anal verge.[4][5] Regional lymphadenopathy, particularly in the inguinal region, is frequently present and may range from small firm lymph nodes to significantly enlarged nodes.[11][12] Systemic examination may reveal signs consistent with secondary syphilis including fever, rash, lymphadenopathy, and hepatosplenomegaly.

The endoscopic appearance of syphilitic proctitis encompasses a broad spectrum of findings, ranging from diffuse erythema and edema to discrete ulcerations and mass-like lesions. Flexible sigmoidoscopy or colonoscopy typically reveals one or more of the following findings: diffuse edema and erythema of the rectal mucosa, friable or hyperemic tissue, multiple erosions, irregular ulcerations with raised or indurated edges, and in some cases ulcerated masses that can range from 15 to 40 millimeters in size.[14][3][15] The ulcers themselves often demonstrate characteristic features including clean bases with raised edges, sometimes described as having an "indurated" or "button-hole" appearance reminiscent of primary chancres.[16] Multiple ulcers may demonstrate various configurations, including eccentric locations, irregular shapes, and occasionally a "kissing" configuration where ulcers are positioned opposite one another on the rectal wall.[11][12]

Imaging findings on computed tomography or magnetic resonance imaging frequently demonstrate abnormalities suggestive of malignancy, contributing to diagnostic confusion. Typical findings include circumferential or segmental rectal wall thickening extending up to several centimeters, perirectal fat stranding, and multiple enlarged mesorectal lymph nodes.[9][14][4][3][11][17] The extent of wall thickening and inflammatory changes can mimic locally advanced rectal cancer, with some cases demonstrating severe stricturing or mass-like lesions suspicious for malignancy.[17] Magnetic resonance imaging may demonstrate high signal intensity in T2-weighted images within the rectal wall and mucosal thickening, findings that are nonspecific and seen in both malignancy and infectious or inflammatory processes.[11][12]

In patients with advanced HIV disease or profound immunosuppression, syphilitic proctitis can present with particularly severe manifestations. Case reports document unusually extensive involvement in patients with CD4 counts below 50 cells per microliter, with severe inflammation potentially progressing to large bowel obstruction.[17][18] One documented case of severe rectal syphilis in a patient with CD4 count of 39 cells per microliter presented with imaging findings mimicking obstructing rectal cancer, requiring careful differentiation from malignancy before appropriate treatment could be initiated.[18]

Diagnostic Evaluation and Laboratory Interpretation

The diagnosis of syphilitic proctitis requires a multimodal approach incorporating clinical history, serologic testing, endoscopic findings, and histopathologic examination. No single test is sufficiently sensitive or specific for definitive diagnosis in all cases, necessitating integration of multiple diagnostic modalities. A comprehensive history is essential, with particular attention to sexual practices and specific inquiry regarding receptive anal intercourse, number of sexual partners, and whether any partners have had syphilis or HIV diagnoses. This detailed sexual history often proves crucial, as it raises clinical suspicion necessary to prompt appropriate diagnostic testing.

Serologic Testing

Serologic diagnosis of syphilis relies on two categories of tests: nontreponemal tests (also called screening tests) that detect antibodies reactive to lipoidal antigens, and treponemal tests that detect antibodies specific to T. pallidum.[19][20] Standard laboratory practice recommends performing both test categories sequentially to confirm diagnosis, as relying on a single test may result in either false positives or false negatives. Nontreponemal tests including rapid plasma reagin (RPR) and Venereal Disease Research Laboratory (VDRL) assays are typically performed first as screening tests. These tests should be reported with quantitative titers (e.g., 1:4, 1:8, 1:16) rather than qualitative results alone, as titer changes are used to assess treatment response and monitor for reinfection.[21][20]

In primary syphilis, nontreponemal tests may be negative early in infection, particularly within the first 2 weeks after the chancre appears. A negative RPR or VDRL test therefore does not exclude early primary syphilis, and if clinical suspicion is high, testing should be repeated at 2 to 4 weeks or empiric treatment considered.[20] In secondary syphilis, nontreponemal tests are nearly uniformly positive, though the "prozone effect" (false negative results at very high antibody titers due to failure of proper antibody-antigen lattice formation) may occur and can be identified by performing serial dilutions of the serum.[19] Among patients with syphilitic proctitis specifically, documented cases demonstrate RPR titers ranging from 1:4 to 1:128 or higher depending on infection stage and individual host factors.[1][11][22][54]

Treponemal tests including fluorescent treponemal antibody-absorbed (FTA-ABS), T. pallidum particle agglutination (TPPA), T. pallidum hemagglutination assay (TPHA), and enzyme immunoassay (EIA) methods detect antibodies specific to T. pallidum antigens.[19][20] These tests become positive within 2 to 5 weeks after initial infection and typically remain positive throughout life even after successful treatment, making them valuable confirmatory tests but less useful for assessing treatment response or detecting reinfection. Current CDC recommendations suggest that treponemal tests may be used as initial screening tests in a reverse algorithm approach, followed by nontreponemal testing to confirm active infection.[19] The TPPA test is currently preferred over FTA-ABS for routine use.[19]

Direct Detection Methods

Direct visualization or identification of T. pallidum from clinical specimens provides confirmatory evidence of syphilitic infection. Dark-field microscopy (DFM), though requiring specialized equipment and trained personnel, remains a rapid point-of-care method for identifying spirochetes in specimens from primary or secondary syphilitic lesions.[23][52] Dark-field microscopy demonstrates sensitivity of 75 to 100 percent in primary syphilis and 58 to 71 percent in secondary syphilis when compared with clinical diagnosis and laboratory findings.[23] However, dark-field microscopy requires immediate examination (ideally within 20 minutes) before treponemes lose motility, and should not be performed on oral or rectal specimens due to the presence of non-pathogenic commensal treponemes that cannot be reliably differentiated from T. pallidum morphologically.[23][52] Therefore, dark-field microscopy has limited utility for diagnosing rectal syphilis.

Direct fluorescence antibody (DFA) testing using monoclonal antibodies against T. pallidum offers better specificity than dark-field microscopy for rectal specimens, with sensitivity ranging from 73 to 100 percent in primary lesions and appropriate specificity for use even on oral and anogenital sites.[52] Immunohistochemical staining of histopathologic sections using antibodies against T. pallidum demonstrates excellent specificity, with sensitivity ranging from 49 to 92 percent compared with clinical diagnosis.[52] Warthin-Starry staining, a special silver stain, can identify spirochetes in tissue samples and has been documented in multiple case reports of syphilitic proctitis, though sensitivity is variable and negative results do not exclude syphilis.[1][2]

Nucleic Acid Amplification Testing

Polymerase chain reaction (PCR) testing for T. pallidum DNA using various molecular targets offers high sensitivity and specificity for direct detection of the organism. PCR testing of rectal biopsies demonstrates reported sensitivity of 70 to 95 percent with specificity of 92 to 98 percent,[1][2] substantially exceeding the performance of traditional histologic staining methods. Studies evaluating performance of nucleic acid amplification tests targeting tpp47 or polA genes have demonstrated positive agreement with dark-field microscopy ranging from 87 to 95 percent in primary lesions.[52] While PCR testing offers excellent sensitivity and specificity, it is not universally available in all laboratories and represents a more resource-intensive diagnostic approach than serologic testing.

Cerebrospinal Fluid Analysis

Given that neurosyphilis can occur at any stage of syphilis and that CNS invasion occurs in the majority of T. pallidum infections, evaluation for neurosyphilis should be considered in patients with documented syphilitic proctitis, particularly if neurologic symptoms are present. Cerebrospinal fluid (CSF) analysis should include cell count (predominantly lymphocytes), protein level, and CSF VDRL testing (the gold standard for neurosyphilis diagnosis).[58] CSF VDRL positivity in the setting of reactive serum serologic tests and supporting clinical or CSF laboratory abnormalities confirms neurosyphilis diagnosis. CSF examination is particularly important in HIV-positive patients and those with symptoms suggestive of neurologic involvement including headache, vision changes, or altered mental status.[22]

One documented case of syphilitic proctitis included findings of mild cerebrospinal fluid pleocytosis with elevated protein, positive treponemal serology in CSF, and negative CSF RPR, consistent with early neurosyphilis alongside rectal manifestations.[22] This case illustrates that syphilitic proctitis may represent only one manifestation of systemic infection and that comprehensive evaluation should assess for CNS involvement particularly in high-risk populations.

Differential Diagnosis and Diagnostic Challenges

The clinical, endoscopic, and radiologic features of syphilitic proctitis present a formidable diagnostic challenge due to their capacity to mimic numerous other serious conditions. The most common misdiagnosis is rectal or colorectal cancer, as imaging findings of circumferential wall thickening with lymphadenopathy and endoscopic findings of irregular mass-like lesions are consistent with malignancy.[9][14][4][5][11][22] Multiple case reports document initial clinical suspicion for rectal cancer based on imaging and endoscopic appearance, with staging workup proceeding before alternative diagnoses were considered.[9][14][4][5][11][22][17]

Inflammatory bowel disease, particularly Crohn's disease and ulcerative colitis, represents another frequent diagnostic consideration in patients presenting with rectal ulceration and inflammation.[24] The chronic nature of symptoms in some syphilitic proctitis cases, combined with findings of rectal ulceration and inflammation on endoscopy, may lead clinicians to diagnose inflammatory bowel disease inappropriately.[24] One documented case illustrates this pitfall, where a patient presenting with rectal ulceration was initially evaluated for Crohn's disease based on endoscopic findings before detailed sexual history and serologic testing revealed syphilitic proctitis.[24]

Other infectious causes of proctitis enter the differential diagnosis, including those caused by Chlamydia trachomatis (including lymphogranuloma venereum strains), Neisseria gonorrhoeae, herpes simplex virus, and cytomegalovirus.[25][16] In immunocompromised patients with very low CD4 counts, opportunistic pathogens including CMV must be considered.[3][18] Multiple case reports include initial treatment with antibiotics empirically covering gonococcal and chlamydial infection before syphilis serologic testing was performed, and before appropriate diagnosis and management could be initiated.[14][13]

Lymphoproliferative disorders including lymphoma may enter the differential diagnosis when imaging demonstrates rectal thickening with enlarged lymph nodes and biopsy reveals dense lymphocytic infiltration.[22] One documented case presented with imaging findings raising suspicion for lymphoma before serologic testing and clinical correlation established syphilitic proctitis.[22] Other rare conditions that may mimic syphilitic proctitis include solitary rectal ulcers, chancroid (caused by Haemophilus ducreyi), viral anorectal ulcers, and various neoplastic processes.

The diagnostic challenge is compounded by several factors. First, histopathologic findings are often nonspecific, demonstrating chronic inflammation with lymphocytic and plasma cell infiltration in many conditions.[9][14][4][5] Second, immunohistochemical staining for spirochetes may be negative even in confirmed cases, as the organisms may be sparse and not uniformly distributed throughout tissue samples.[14][13] Third, the rarity of syphilitic proctitis creates a low baseline prevalence in many clinical settings, leading clinicians to have reduced clinical suspicion and delayed consideration of this diagnosis. Fourth, many patients presenting with rectal symptoms may not spontaneously volunteer detailed sexual history without direct questioning from healthcare providers.

Treatment and Clinical Decision-Making

Benzathine penicillin G remains the first-line therapeutic agent for all stages of syphilis, including syphilitic proctitis, due to its long-standing effectiveness, acceptable tolerability, and decades of accumulated clinical experience.[21][55]``[59] For patients with early syphilis (primary, secondary, and early latent syphilis of less than one year duration), the standard treatment regimen is benzathine penicillin G 2.4 million units administered as a single intramuscular injection.[21][55] This dosing schedule achieves adequate serum levels to maintain T. pallidum above the minimum inhibitory concentration for extended periods, exploiting the slow growth rate of the organism (approximately one doubling per day in vivo) to allow penicillin's bactericidal activity to be effective.[26][21][13]

However, considerable variability exists in published case reports regarding specific dosing and treatment duration for syphilitic proctitis specifically.[14][3][13][15] Some cases have been successfully treated with the standard single dose of benzathine penicillin G, while others required extended regimens including weekly injections for 3 weeks, particularly in cases where late latent or tertiary syphilis was documented or when neurosyphilis was present.[4][5][21][27] Treatment of patients with documented late latent or tertiary syphilis (defined as infection lasting longer than one year) consists of benzathine penicillin G 2.4 million units administered intramuscularly weekly for 3 weeks (total 7.2 million units).[21][55]

When neurosyphilis is diagnosed or documented by CSF analysis, the treatment regimen must be modified to achieve adequate CSF penetration. Benzathine penicillin G does not achieve adequate levels in cerebrospinal fluid; therefore, patients with neurosyphilis require intravenous aqueous crystalline penicillin G at high doses (18-24 million units daily, typically administered as 3-4 million units every 4 hours) for 10 to 14 days.[8][28][21] One case of syphilitic proctitis complicated by neurosyphilis documented with positive CSF serology was successfully treated with 3 weeks of intravenous benzyl penicillin, resulting in resolution of both rectal and neurologic manifestations including visual complaints.[4][5]

The Jarisch-Herxheimer reaction represents an important potential adverse effect occurring within hours of initiating antibiotics for syphilis and resulting from massive release of inflammatory cytokines following spirochete death.[29][30][31] This reaction manifests as acute fever, myalgias, headache, tachycardia, and occasionally more severe systemic symptoms, with onset typically within 12 hours of treatment and duration usually less than 24 hours.[29] A recent large clinical trial found the Jarisch-Herxheimer reaction occurred in 23.7 percent of 249 adults treated with benzathine penicillin G for early syphilis, with median symptom onset at 4.9 hours and median duration of 12.8 hours.[29] The reaction was associated with secondary syphilis stage and absence of HIV infection, and notably was associated with successful treatment response at 6 months.[29]

Recognition and appropriate management of the Jarisch-Herxheimer reaction is essential to prevent inappropriate diagnostic confusion or treatment cessation. Management consists primarily of supportive care including antipyretics for fever and analgesics for myalgias; severe reactions may require corticosteroids or other supportive measures in intensive care settings.[17] One case of severe rectal syphilis presenting with large bowel obstruction demonstrated Jarisch-Herxheimer reaction with worsening tachypnea, tachycardia, diaphoresis, and erythematous rash within 6 hours of penicillin administration; however, supportive care allowed symptom resolution by the following morning and complete resolution of bowel obstruction over subsequent days.[17]

Alternative Treatment Regimens

For patients with documented penicillin allergy, alternative treatment regimens exist though with substantially less robust clinical data supporting their efficacy. Doxycycline at a dose of 100 milligrams orally twice daily for 14 days represents the most commonly recommended alternative for nonpregnant patients with primary or secondary syphilis.[21][55] Tetracycline at 500 milligrams orally four times daily for 14 days is also effective but associated with worse gastrointestinal side effects and less favorable adherence compared to doxycycline.[21][55]

Limited clinical evidence supports use of ceftriaxone (1 gram daily either intramuscularly or intravenously for 10 days) for treating primary and secondary syphilis, though optimal dosing and duration have not been definitively established.[21][55] Cross-reactivity between penicillin and third-generation cephalosporins occurs in approximately 1-3 percent of patients with penicillin allergy, so cephalosporins should be used with caution in patients with documented immediate hypersensitivity reactions to penicillin.[21][55]

Notably, azithromycin should not be used for syphilis treatment due to documented T. pallidum chromosomal mutations conferring resistance and multiple documented treatment failures in various U.S. geographic areas.[21][55] For patients with penicillin allergy whose clinical adherence with oral therapy cannot be assured, penicillin desensitization followed by standard penicillin therapy is recommended.[21][55]

Treatment Response and Follow-Up

The goals of syphilis treatment are clinical and serologic cure, defined respectively as healing of lesions and prevention of sexual transmission, and by decline of nontreponemal antibody titers by fourfold or greater within 6 to 12 months for early syphilis (or 12-24 months for late syphilis).[21][13][55] Clinical response to therapy for syphilitic proctitis is often rapid, with many documented cases showing complete or near-complete resolution of symptoms and imaging abnormalities within weeks of treatment initiation. Follow-up colonoscopy performed in the weeks to months following treatment frequently reveals complete healing of ulcers or marked improvement in mucosal appearance, with rectal masses demonstrating regression or complete resolution.[14][3][13][15]

Serologic follow-up testing should be performed at 6 and 12 months after treatment, comparing nontreponemal titers to baseline values at the time of treatment.[21][55] A fourfold decrease in nontreponemal titer (representing a ≥4 dilution step decrease) signifies adequate serologic response. Approximately 79 percent of patients with early syphilis achieve this serologic cure by 6 months, while approximately 21 percent remain "serofast" (defined as ≤2-fold decrease in titer or no change in titer).[56] Serofast status does not necessarily indicate treatment failure and does not require retreatment in the absence of clinical evidence of relapse or reinfection.[60]

Patients who do not achieve fourfold decline in nontreponemal titers are classified as having "serologic nonresponse," requiring evaluation for possible neurosyphilis through CSF analysis and lumbar puncture.[21][13][55] If CSF examination reveals evidence of neurosyphilis, retreatment with intravenous penicillin is indicated. In patients without CSF abnormalities despite serologic nonresponse, management remains controversial, though most experts recommend clinical follow-up without additional treatment.

Complications and Potential Adverse Outcomes

Without prompt diagnosis and treatment, syphilitic proctitis can progress to serious complications affecting multiple organ systems. Neurosyphilis represents one of the most significant potential complications, occurring when T. pallidum establishes infection in the central nervous system. Early neurosyphilis manifestations including syphilitic meningitis can present with headache, altered mental status, cranial nerve dysfunction, and meningeal signs occurring within months to years of infection.[8][28] Late neurosyphilis manifestations including general paresis and tabes dorsalis develop years to decades after initial infection and cause progressive neurologic deterioration including dementia, personality changes, ataxic gait, and potentially fatal complications.[8][28][32]

Ocular syphilis represents another serious complication that can occur at any stage of infection and may manifest as uveitis, optic neuropathy, retinal vasculitis, or other intraocular inflammation.[8][64] Untreated ocular syphilis can progress rapidly to permanent blindness.[8][64] One case of syphilitic proctitis documented concurrent ocular involvement with blurred vision, later confirmed to have positive cerebrospinal fluid serology consistent with neurosyphilis.[4][5] Otosyphilis causing sensorineural hearing loss, tinnitus, or vertigo also can occur at any stage and may result in permanent auditory dysfunction if untreated.[64]

Cardiovascular syphilis develops predominantly in tertiary syphilis and manifests as syphilitic aortitis, potentially resulting in aortic aneurysm formation and rupture.[10][32][30] While late manifestations, they represent catastrophic complications of untreated syphilis.[32]

Local rectal complications of untreated syphilitic proctitis include stricture formation with potential large bowel obstruction, intestinal perforation, and fistula formation.[1][2][33] One documented case presented with large bowel obstruction secondary to severe syphilitic proctocolitis, requiring recognition and management of this unusual presentation.[17]

Jarisch-Herxheimer reaction, while typically self-limited, can occasionally be severe and require intensive management, particularly in patients with systemic disease or large bacterial burdens. Severe reactions can manifest as shock-like symptoms, exacerbation of existing cardiac or neurologic disease, or uncommonly, fatal outcomes if inadequately managed.

Treatment failures can occur despite appropriate therapy, though remain uncommon with benzathine penicillin G regimens. Serofast status following treatment may represent incomplete immune clearance rather than true treatment failure but complicates assessment of treatment adequacy. Persistent clinical symptoms despite treatment warrant investigation for alternative diagnoses, inadequate dosing or compliance, or potential neurosyphilis.

HIV disease progression can be accelerated by syphilis through multiple mechanisms. Syphilis causes genital ulceration that facilitates HIV transmission and increases infectivity of HIV-positive individuals. Furthermore, syphilis-related immune activation can accelerate CD4 decline in patients with HIV coinfection.[2]

Considerations in Special Populations

HIV Coinfection and Immunocompromised Patients

Patients with documented HIV infection represent a particularly vulnerable population for severe syphilitic proctitis manifestations. The prevalence of syphilis and HIV coinfection is substantial, with estimates ranging from 45 to 79 percent in HIV-positive individuals who have acquired syphilis.[1][2] Among HIV-positive MSM, the prevalence of T. pallidum is substantially elevated compared to the general population, with prevalence reaching 12.1 percent in those with CD4 counts below 200 cells per microliter and who had sexual partners with known HIV infection.[6][34]

Immunosuppression alters the clinical presentation and natural history of syphilis. Patients with advanced HIV disease (CD4 count <200 cells/µL) may present with atypical or severe manifestations of syphilis, including lues maligna (malignant syphilis), an aggressive form of secondary syphilis characterized by extensive ulcerated, nodular, or necrotic skin lesions, systemic symptoms, and high bacterial loads.[7][63] Similarly, syphilitic proctitis in profoundly immunosuppressed patients may present with more extensive involvement, larger masses, and more severe mucosal inflammation than typically observed in immunocompetent patients.[18]

Neurosyphilis occurs with increased frequency in HIV-positive patients, even at relatively preserved CD4 counts.[8][28] Ocular syphilis and otosyphilis similarly occur more frequently in HIV-positive individuals.[64] One case of syphilitic proctitis in a patient with CD4 count of 39 cells per microliter documented unusually severe proctitis with extensive inflammatory involvement requiring special immunohistochemical staining (ERG and CD38 staining) to characterize the inflammatory infiltrate and aid in differential diagnosis from other opportunistic infections or malignancies.[18]

Treatment of syphilis in HIV-positive patients generally follows standard regimens; however, heightened clinical vigilance for neurologic involvement is warranted. Some experts recommend CSF examination and lumbar puncture for all HIV-positive patients with syphilis, though current CDC guidelines do not universally mandate this unless clinical signs or symptoms of neurologic involvement are present.[55]``[64] All HIV-positive patients with syphilis should have HIV viral load measured and antiretroviral therapy optimized, as immune reconstitution may facilitate treatment response.

Pregnancy and Congenital Transmission

While syphilitic proctitis is not a pregnancy-related condition per se, recognition that pregnant women with syphilis are at risk for devastating vertical transmission is essential. Maternal syphilis can result in miscarriage, stillbirth, prematurity, low birth weight, and congenital syphilis in surviving infants.[62]``[66] Untreated maternal syphilis transmits to the fetus in nearly all cases if infection occurs in the first and second trimesters and in approximately 70 percent of cases if infection occurs in the third trimester.[62] Congenital syphilis cases have more than tripled in recent years, with nearly 4,000 cases reported in 2024 alone, the highest number in one year since 1994.[66]

All pregnant women should receive syphilis testing at their first prenatal visit, and many experts recommend repeat testing during the third trimester and at delivery to detect infections or reinfections acquired during pregnancy.[62]``[66] Pregnant women diagnosed with syphilis should be desensitized to penicillin if allergic and treated with benzathine penicillin G according to stage of infection, as penicillin remains the only reliably effective agent for prevention of congenital syphilis.[21][55]

Implications for Clinical Practice

The recognition and appropriate diagnosis of syphilitic proctitis requires clinicians to maintain high clinical suspicion, particularly when encountering patients with rectal symptoms and history of receptive anal intercourse or men who have sex with men status. A thorough sexual history, explicitly addressing receptive anal intercourse, number of partners, use of barrier protection, and partners' STI or HIV status, is essential in all patients presenting with anorectal symptoms. Detailed history-taking may require culturally competent, nonjudgmental communication to elicit accurate information.

Serologic testing for syphilis should be performed routinely in patients presenting with proctitis, particularly when initial infectious workup for gonococcal and chlamydial infection is being pursued.[25][3] When imaging demonstrates rectal wall thickening with lymphadenopathy suspicious for malignancy, particularly in patients with MSM history or HIV infection, syphilis serologic testing should be incorporated into the diagnostic evaluation before proceeding with staging workup or surgical consultation for presumed cancer.

Collaboration between specialists—including gastroenterologists performing endoscopy, radiologists interpreting imaging, pathologists reviewing biopsies, and infectious disease specialists—facilitates appropriate diagnosis.[22] Communication regarding clinical and sexual history is essential to ensure that all specialists are considering infectious etiologies including syphilis in the differential diagnosis. Early consultation with infectious disease specialists may accelerate appropriate diagnosis and prevent unnecessary procedures.

For patients in whom syphilis diagnosis is confirmed, comprehensive evaluation is warranted. Lumbar puncture for cerebrospinal fluid analysis should be performed in patients with neurologic symptoms or signs. HIV testing should be offered to all patients with syphilis whose HIV status is unknown or previously negative. Ophthalmologic evaluation is warranted for patients with visual complaints or ocular symptoms. Sexual partners should be identified and offered testing and treatment to prevent reinfection and reduce community transmission.

Patient counseling regarding treatment expectations, including potential for Jarisch-Herxheimer reaction, facilitates appropriate management and prevents misinterpretation of post-treatment symptoms as treatment failure. Patients should be counseled regarding sexual transmission and the importance of partner notification and treatment. Follow-up serologic testing at 6 and 12 months is essential to document treatment response and detect possible reinfection.

Conclusion

Syphilitic proctitis, while rare, represents an important clinical entity that must be recognized as part of the differential diagnosis for patients with anorectal pathology, particularly those with history of receptive anal intercourse or known MSM status. The condition's capacity to mimic rectal malignancy and inflammatory bowel disease, combined with its nonspecific clinical presentation and lack of pathognomonic features, creates substantial diagnostic challenge. However, the dramatic clinical and radiologic improvement following appropriate penicillin therapy, combined with the availability of effective serologic and microbiologic diagnostic methods, provides strong incentive for maintaining clinical vigilance and considering this diagnosis systematically.

The reemergence of syphilis in developed countries over recent decades, the high frequency of syphilis and HIV coinfection, and the documented association between syphilis and increased neurosyphilis risk in immunocompromised populations underscore the ongoing importance of this infection. Clinicians serving populations with elevated syphilis prevalence or caring for MSM and HIV-positive patients have particular responsibility to maintain awareness of syphilitic proctitis and incorporate serologic testing into diagnostic algorithms for anorectal disease.[71]``[75]

Early recognition and prompt treatment with benzathine penicillin G prevent serious complications including neurosyphilis, cardiovascular involvement, and permanent organ dysfunction. The integration of detailed sexual history, appropriate serologic testing, recognition of compatible imaging and endoscopic findings, and histopathologic examination provides the clinical foundation for diagnosis. Partner notification and treatment remain essential public health interventions to prevent community transmission and reinfection. Continued surveillance, epidemiologic study, and provider education regarding syphilitic proctitis will enhance early recognition and treatment, thereby reducing morbidity and mortality associated with this condition.

Fuentes

  1. https://www.revistagastroenterologiamexico.org/en-rectal-syphilis-a-case-report-articulo-S2255534X23000026
  2. https://www.cdc.gov/syphilis/about/index.html
  3. https://my.clevelandclinic.org/health/diseases/5964-proctitis
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC4900787/
  5. https://my.clevelandclinic.org/health/diseases/24772-neurosyphilis
  6. https://www.ncbi.nlm.nih.gov/books/NBK557820/
  7. https://www.ovid.com/journals/stds/pdf/10.1097/olq.0000000000001387~the-terms-serofast-and-serological-nonresponse-in-the-modern
  8. https://academic.oup.com/ofid/article/7/Supplement_1/S772/6058023
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC3097953/
  10. https://www.ncbi.nlm.nih.gov/books/NBK384905/
  11. https://academic.oup.com/jscr/article/2024/11/rjac102/7879561
  12. https://www.cdc.gov/std-ips/php/about/index.html
  13. https://onlinelibrary.wiley.com/doi/full/10.1002/aid2.13165
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC8042098/
  15. https://dermnetnz.org/topics/syphilis
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC2824876/
  17. https://en.wikipedia.org/wiki/Syphilis
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC4442722/
  19. https://www.cdc.gov/std/treatment-guidelines/syphilis.htm
  20. https://www.cdc.gov/sti-statistics/annual/index.html
  21. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830226
  22. https://jjgastro.com/articles/JJGR-v5-1222.html
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC12418602/
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC10978595/
  25. https://www.cdc.gov/std/treatment-guidelines/proctitis.htm
  26. https://www.cdc.gov/std/treatment-guidelines/p-and-s-syphilis.htm
  27. https://www.mayoclinic.org/diseases-conditions/syphilis/symptoms-causes/syc-20351756
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC7751213/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC10310909/
  30. https://www.cdc.gov/syphilis/about/about-congenital-syphilis.html
  31. https://onlinelibrary.wiley.com/doi/10.1111/ijd.15880
  32. https://www.ncbi.nlm.nih.gov/books/NBK537087/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC12286282/
  34. https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/publicationsohpsyphilis-testing-and-lab-interpretation.pdf
  35. https://journals.asm.org/doi/10.1128/jcm.01240-11
  36. https://www.mayoclinic.org/diseases-conditions/proctitis/symptoms-causes/syc-20376933
  37. https://www.ncbi.nlm.nih.gov/books/NBK540979/
  38. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540452/all/Proctitis_%5BInfectious_and_Sexually_transmitted%5D
  39. https://www.dovepress.com/prevalence-of-hiv-treponema-pallidum-and-their-coinfection-in-men-who--peer-reviewed-fulltext-article-HIV
  40. https://www.ageb.be/Articles/Volume%2081%20(2018)/Fasc3/13-Struyve-2.pdf
  41. https://www.cdc.gov/mmwr/volumes/73/rr/rr7301a1.htm
  42. https://www.ncbi.nlm.nih.gov/books/NBK534780/
  43. https://jsstd.org/dark-ground-microscopy-for-identification-of-treponema-pallidum/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC7312206/
  45. https://academic.oup.com/cid/article/53/11/1092/306119
  46. https://bhm.scholasticahq.com/article/72802-the-great-imitator-a-rare-case-of-lues-maligna-in-an-hiv-positive-patient
  47. https://www.cdc.gov/syphilis/hcp/neurosyphilis-ocular-syphilis-otosyphilis/index.html
  48. https://www.ncbi.nlm.nih.gov/books/NBK558957/
  49. https://academic.oup.com/cid/article/53/suppl_3/S79/312189

Respuesta generada por inteligencia artificial a partir de las fuentes citadas. Verifica las fuentes antes de aplicarla.

¿Tienes una pregunta sobre tu propio caso? Itaca responde con fuentes en segundos.

Hacer una pregunta

Más preguntas sobre gastroenteritis